DARE - Dare Bioscience Inc. (DARE) CEO Sabrina Martucci Johnson on Q1 2022 Results - Earnings Call Transcript

Dare Bioscience, Inc. (DARE) Q1 2022 Earnings Conference Call May 12, 2022, 16:30 PM ET Company Participants Sabrina Martucci Johnson - President and Chief Executive Officer John Fair - Chief Strategy Officer Lisa Walters-Hoffert - Chief Financial Officer Conference Call Participants Zegbah Jallah - ROTH Capital Partners Douglas Tsao - H.C. Wainwright Kumaraguru Raja - Brookline Capital Markets Presentation Operator Welcome to the conference call hosted by Dare Bioscience to review the company's financial results for the year ended March 31, 2022, and to provide a general business update. This call is being recorded. My name is Delfin, and I'll be your operator today. With us today are Ms. Sabrina Martucci Johnson, Dare's President and Chief Executive Officer; Mr. John Fair, Dare's Chief Strategy Officer; and Ms. Lisa Walters-Hoffert, Dare's Chief Financial Officer. Ms. Johnson, please proceed. Sabrina Martucci Johnson Thank you. Good afternoon, and welcome to our First Quarter

For further details see:

Dare Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q1 2022 Results - Earnings Call Transcript